These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1421656)

  • 1. Impact of therapeutic drug monitoring of intravenous theophylline regimens on serum theophylline concentrations in the medical intensive care unit.
    Dager WE; Albertson TE
    Ann Pharmacother; 1992 Oct; 26(10):1287-91. PubMed ID: 1421656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three theophylline dosing methods in pediatric patients.
    Godley PJ; Karboski JA; Godley SE; Edwards GA; Moore ES; Sagraves R
    DICP; 1991 Feb; 25(2):179-85. PubMed ID: 2058190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients.
    Fradette M; Babich M; Friesen EG; Archibald JS; Babul N
    Clin Ther; 1994; 16(2):160-8. PubMed ID: 8062311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vancomycin therapeutic drug monitoring on patient care.
    Welty TE; Copa AK
    Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist intervention on oral theophylline therapy in adult inpatients.
    Blackbourn J; Sunderland VB
    Drug Intell Clin Pharm; 1987 Oct; 21(10):811-6. PubMed ID: 3428141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
    Kamada AK; Hill MR; Brenner AM; Szefler SJ
    Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline toxicity: clinical features of 116 consecutive cases.
    Sessler CN
    Am J Med; 1990 Jun; 88(6):567-76. PubMed ID: 2189301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are theophylline "levels" a reliable indicator of compliance?
    Kossoy AF; Hill M; Lin FL; Szefler SJ
    J Allergy Clin Immunol; 1989 Jul; 84(1):60-5. PubMed ID: 2754145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TDM (therapeutic drug monitoring) for dosing theophylline].
    Ueda W
    Masui; 1991 Oct; 40(10):1536-41. PubMed ID: 1766103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline disposition in Korean patients with congestive heart failure.
    Jeong CS; Hwang SC; Jones DW; Ryu HS; Sohn K; Sands CD
    Ann Pharmacother; 1994 Mar; 28(3):396-401. PubMed ID: 8193433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequacy of FDA dosing guidelines for intravenous theophylline.
    Lopez LM; Russell WL; Hemmes RJ; Ryerson EG
    Drug Intell Clin Pharm; 1984 Dec; 18(12):987-91. PubMed ID: 6510225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline pharmacokinetics in Thai children.
    Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of intravenous cimetidine dosage regimens on the disposition of theophylline.
    Gutfeld MB; Welage LS; Walawander CA; Wilton JH; Harrison NJ
    J Clin Pharmacol; 1989 Jul; 29(7):665-9. PubMed ID: 2760260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer assisted design of a theophylline dosing regimen in acute bronchospasm: serum concentrations and clinical outcome.
    Verner D; Seligmann H; Platt S; Dany S; Almog S; Zulty L; Halkin H; Ezra D
    Eur J Clin Pharmacol; 1992; 43(1):29-33. PubMed ID: 1505605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-based i.v. theophylline therapy.
    Donahue T; Dotter J; Alexander G; Sadaj JM
    Hosp Pharm; 1989 Jun; 24(6):440, 442-8, 460. PubMed ID: 10293972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
    Georgitis JW; Szefler SJ; Baswell B; Shen DD
    Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.